Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
89.2M
-
Shares change
-
+12.4M
-
Total reported value, excl. options
-
$3.18B
-
Value change
-
+$488M
-
Put/Call ratio
-
0.33
-
Number of buys
-
135
-
Number of sells
-
-65
-
Price
-
$35.74
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2021
244 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q3 2021.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.2M shares
of 119M outstanding shares and own 74.72% of the company stock.
Largest 10 shareholders include BlackRock Inc. (13.3M shares), FMR LLC (12.5M shares), VANGUARD GROUP INC (5.31M shares), STATE STREET CORP (4.31M shares), PFM Health Sciences, LP (3.16M shares), Polar Capital Holdings Plc (3.01M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.89M shares), FARALLON CAPITAL MANAGEMENT LLC (2.73M shares), WASATCH ADVISORS INC (2.65M shares), and PICTET ASSET MANAGEMENT SA (2.39M shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.